Emcure Pharmaceuticals Announcements
Confirmation under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018, for the quarter ended December 31, 2025.
07 Jan, 2026 | 01:24pm • Source: BSE
Press Release titled "Emcure expands Weight Management Therapy access with launch of Poviztra".
22 Dec, 2025 | 11:40am • Source: BSE
Intimation of schedule of Analyst/ Investor Meeting(s)
01 Dec, 2025 | 09:13pm • Source: BSE
Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, regarding search and seizure/ inspection operation conducted by Good & Service...
27 Nov, 2025 | 04:38pm • Source: BSE
Mr. Chetan Sharma (FCS:8352) has submitted his resignation from post of company Secretary and Compliance Officer & Key Managerial Personnel of the Company, with effect...
21 Nov, 2025 | 05:57pm • Source: BSE
Emcure Pharmaceuticals Limited has informed the Exchange about Investor Presentation
19 Nov, 2025 | 12:29pm • Source: NSE
Investor Presentation for Investor Conferences, to be attended by officials of the Company, on November 19, 2025 and November 20, 2025
19 Nov, 2025 | 11:07am • Source: BSE
Transcript of Earnings Call - Q2 FY26
17 Nov, 2025 | 04:36pm • Source: BSE
Intimation of schedule of Analyst/ Investor Meeting(s)
14 Nov, 2025 | 06:24pm • Source: BSE
Intimation of schedule of Analyst/ Investor Meeting(s)
14 Nov, 2025 | 06:21pm • Source: BSE
Audio recording of Earnings Call - Q2 FY26
11 Nov, 2025 | 05:06pm • Source: BSE
Unaudited Financial Results (Consolidated and Standalone) for the quarter and half-year ended September 30, 2025
11 Nov, 2025 | 01:39pm • Source: BSE
Unaudited Financial Results (Consolidated and Standalone) for the quarter and half-year ended September 30, 2025
11 Nov, 2025 | 01:35pm • Source: BSE
Emcure Pharmaceuticals Limited has informed the Exchange regarding a press release dated November 10, 2025, titled "Novo Nordisk India partners with Emcure Pharma to commercialise...
10 Nov, 2025 | 12:30pm • Source: NSE
A press release titled "Novo Nordisk India partners with Emcure Pharma to commercialise Poviztra in India as a second brand of Wegovy."
10 Nov, 2025 | 11:26am • Source: BSE
Intimation for Earnings Call - Q2 FY26
03 Nov, 2025 | 05:49pm • Source: BSE
Emcure Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2025 ,inter alia, to consider and...
03 Nov, 2025 | 05:32pm • Source: BSE
Intimation under Regulation 30 of the SEBI Listing Regulations, 2015 - Revision in Credit Rating
17 Oct, 2025 | 06:48pm • Source: BSE
Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("SEBI Listing Regulations") - US FDA inspection at our manufacturing facility...
10 Oct, 2025 | 01:42pm • Source: BSE
Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Revision in Credit Ratings
08 Oct, 2025 | 06:41pm • Source: BSE